Compound information
- Natural Products
- NACP95481
- Molecular Formula
- C14H20N2O4
- Molecular Weight
- 280.14230712 g/mol
- Structure
-
- IUPAC Name
- 6-amino-2-(benzyloxycarbonylamino)hexanoic acid
- InChI
- InChI=1S/C14H20N2O4/c15-9-5-4-8-12(13(17)18)16-14(19)20-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10,15H2,(H,16,19)(H,17,18)
- InChI Key
- OJTJKAUNOLVMDX-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(C(=O)O)CCCCN
- CAS
- SuperClass
- Benzenoids
- Class
- Benzene and substituted derivatives
- SubClass
- Benzyloxycarbonyls
- Source
- CNP0037297
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 101.65 Å2 | LogP | -0.476 |
LogS | -1.721 | LogD | -0.077 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.032 |
HIA | 0.033 | F20 % | 0.991 |
F30 % | 0.112 | Caco-2 | -6.361 |
MDCK | -5.815 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.915 | PPB | 63.488 |
VD | 0.416 | Fu | 0.123 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.558 |
CYP2A6 substrate | 0.453 | CYP2B6 substrate | 0.49 |
CYP2C19 inhibitor | 0.012 | CYP2C19 substrate | 0.472 |
CYP2C8 substrate | 0.54 | CYP2C9 inhibitor | 0.04 |
CYP2C9 substrate | 0.063 | CYP2D6 inhibitor | 0.036 |
CYP2D6 substrate | 0.179 | CYP2E1 substrate | 0.267 |
CYP3A4 inhibitor | 0.037 | CYP3A4 substrate | 0.126 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.853 | CL | 1.601 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.006 | Hepatotoxicity | 0.072 |
Mutagenicity | 0.023 | Rat Oral Acute Toxicity | 0.077 |
FDAMDD | 0.025 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.001 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.02 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.346 | IGC50 | 1.985 |
LC50FM | 3.357 | LC50DM | 4.283 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.222 | NR-AR-LBD | 0.239 |
NR-AhR | 0.003 | NR-Aromatase | 0.049 |
NR-ER | 0.252 | NR-ER-LBD | 0.334 |
NR-PPAR-gamma | 0.452 | SR-ARE | 0.044 |
SR-ATAD5 | 0.316 | SR-HSE | 0.115 |
SR-MMP | 0.01 | SR-p53 | 0.021 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.